Aardvark Therapeutics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Tien-Li Lee, with a market cap of $77.4M.
Common questions about Aardvark Therapeutics, Inc. Common Stock
Aardvark Therapeutics, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 13, 2026.
We use cookies for analytics. See our Privacy and Cookie Policy.